Infectious Disease Molecular Diagnostics Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infectious Disease Molecular Diagnostics Market 

5.1. COVID-19 Landscape: Infectious Disease Molecular Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infectious Disease Molecular Diagnostics Market, By Product

8.1. Infectious Disease Molecular Diagnostics Market, by Product, 2024-2033

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Infectious Disease Molecular Diagnostics Market, By End-use

9.1. Infectious Disease Molecular Diagnostics Market, by End-use, 2024-2033

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Clinics

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Diagnostics Laboratories

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Research Institutes

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Infectious Disease Molecular Diagnostics Market, By Technology 

10.1. Infectious Disease Molecular Diagnostics Market, by Technology, 2024-2033

10.1.1. Polymerase chain reaction (PCR)

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. In Situ Hybridization

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT)

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Chips and Microarrays

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Mass Spectrometry

10.1.5.1. Market Revenue and Forecast (2021-2033)

10.1.6. Sequencing

10.1.6.1. Market Revenue and Forecast (2021-2033)

10.1.7. Transcription Mediated Amplification

10.1.7.1. Market Revenue and Forecast (2021-2033)

10.1.8. Others

10.1.8.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Infectious Disease Molecular Diagnostics Market, By Application 

11.1. Infectious Disease Molecular Diagnostics Market, by Application, 2024-2033

11.1.1. Respiratory Diseases

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Tuberculosis

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Meningitis

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Gastrointestinal Tract Infections

11.1.4.1. Market Revenue and Forecast (2021-2033)

11.1.5. HPV

11.1.5.1. Market Revenue and Forecast (2021-2033)

11.1.6. Sexually Transmitted Infections

11.1.6.1. Market Revenue and Forecast (2021-2033)

11.1.7. Sepsis

11.1.7.1. Market Revenue and Forecast (2021-2033)

11.1.8. Drug Resistance Diseases

11.1.8.1. Market Revenue and Forecast (2021-2033)

11.1.9. Other Infectious Diseases

11.1.9.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Infectious Disease Molecular Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Forecast, by End-use (2021-2033)

12.1.3. Market Revenue and Forecast, by Technology (2021-2033)

12.1.4. Market Revenue and Forecast, by Application (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Forecast, by End-use (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Technology (2021-2033)

12.1.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Forecast, by End-use (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Technology (2021-2033)

12.1.6.4. Market Revenue and Forecast, by Application (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Forecast, by End-use (2021-2033)

12.2.3. Market Revenue and Forecast, by Technology (2021-2033)

12.2.4. Market Revenue and Forecast, by Application (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Forecast, by End-use (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Technology (2021-2033)

12.2.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Forecast, by End-use (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)

12.2.6.4. Market Revenue and Forecast, by Application (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Forecast, by End-use (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Technology (2021-2033)

12.2.7.4. Market Revenue and Forecast, by Application (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Forecast, by End-use (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Technology (2021-2033)

12.2.8.4. Market Revenue and Forecast, by Application (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Forecast, by End-use (2021-2033)

12.3.3. Market Revenue and Forecast, by Technology (2021-2033)

12.3.4. Market Revenue and Forecast, by Application (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Forecast, by End-use (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Technology (2021-2033)

12.3.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Forecast, by End-use (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)

12.3.6.4. Market Revenue and Forecast, by Application (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Forecast, by End-use (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Technology (2021-2033)

12.3.7.4. Market Revenue and Forecast, by Application (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Forecast, by End-use (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Technology (2021-2033)

12.3.8.4. Market Revenue and Forecast, by Application (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Forecast, by End-use (2021-2033)

12.4.3. Market Revenue and Forecast, by Technology (2021-2033)

12.4.4. Market Revenue and Forecast, by Application (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Forecast, by End-use (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Technology (2021-2033)

12.4.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Forecast, by End-use (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)

12.4.6.4. Market Revenue and Forecast, by Application (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Forecast, by End-use (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Technology (2021-2033)

12.4.7.4. Market Revenue and Forecast, by Application (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Forecast, by End-use (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Technology (2021-2033)

12.4.8.4. Market Revenue and Forecast, by Application (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Forecast, by End-use (2021-2033)

12.5.3. Market Revenue and Forecast, by Technology (2021-2033)

12.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Forecast, by End-use (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Technology (2021-2033)

12.5.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Forecast, by End-use (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Technology (2021-2033)

12.5.6.4. Market Revenue and Forecast, by Application (2021-2033)

Chapter 13. Company Profiles

13.1. Sysmex Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Siemens Healtineers AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Qiagen

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Grifols S.A.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Illumina, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Hologic, Inc. (Gen-Probe)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Becton, Dickinson and Company

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Agilent Technologies, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Bio-Rad Laboratories, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. F. Hoffmann-La Roche Ltd

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms